ICA structure
|
Common Name | ICA | ||
---|---|---|---|---|
CAS Number | 3374-88-7 | Molecular Weight | 254.310 | |
Density | 1.3±0.1 g/cm3 | Boiling Point | 466.4±48.0 °C at 760 mmHg | |
Molecular Formula | C13H10N4S | Melting Point | N/A | |
MSDS | N/A | Flash Point | 235.9±29.6 °C |
Use of ICAICA (N-(pyridin-2-yl)-4-(pyridin-2-yl)thiazol-2-amine) is a SK channel inhibitor that has antileishmanial activity with an IC50 of 2.1 µM. |
Name | ICA |
---|---|
Synonym | More Synonyms |
Description | ICA (N-(pyridin-2-yl)-4-(pyridin-2-yl)thiazol-2-amine) is a SK channel inhibitor that has antileishmanial activity with an IC50 of 2.1 µM. |
---|---|
Related Catalog | |
Target |
IC50: 2.1 µM (Antileishmanial)[1] |
In Vitro | The SK channel inhibitor ICA exhibits antiarrhythmic effects. ICA prevents electrically induced runs of atrial fibrillation in the isolated right atrium and induces atrial postrepolarization refractoriness and depolarizes resting membrane potential. ICA at 1 to 10 μM slows conduction velocity. At increased pacing frequencies, SK channel inhibition by ICA (10-30 μM) demonstrates prominent depression of other sodium channel-dependent parameters[2]. |
References |
Density | 1.3±0.1 g/cm3 |
---|---|
Boiling Point | 466.4±48.0 °C at 760 mmHg |
Molecular Formula | C13H10N4S |
Molecular Weight | 254.310 |
Flash Point | 235.9±29.6 °C |
Exact Mass | 254.062622 |
LogP | 1.39 |
Vapour Pressure | 0.0±1.2 mmHg at 25°C |
Index of Refraction | 1.694 |
Storage condition | 2-8℃ |
N-[4-(2-Pyridinyl)-1,3-thiazol-2-yl]-2-pyridinamine |
Pyridin-2-yl-(4-pyridin-2-yl-thiazol-2-yl)-amine |
TCMDC-124275 |
N-[4-(Pyridin-2-yl)-1,3-thiazol-2-yl]pyridin-2-amine |
2-Pyridinamine, N-[4-(2-pyridinyl)-2-thiazolyl]- |